Edition:
United Kingdom

Claris Lifesciences Ltd (CLAI.BO)

CLAI.BO on Bombay Stock Exchange

348.40INR
15 Dec 2017
Change (% chg)

Rs-0.25 (-0.07%)
Prev Close
Rs348.65
Open
Rs349.70
Day's High
Rs350.05
Day's Low
Rs344.95
Volume
93,571
Avg. Vol
159,680
52-wk High
Rs430.10
52-wk Low
Rs291.00

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep 43.10 3.578
Jun 31.32 -1.647
FY 2017 Mar '17 44.11 -1.064
Dec 126.20 -3.853
Sep 17.92 -1.271
Jun 13.55 -0.840
FY 2016 Mar '16 182.38 -1.659
Dec 256.68 -16.928
Sep 1,972.88 2.199
Jun 1,870.79 3.526
FY 2015 Mar '15 1,579.21 1.913
Dec 6,418.31 25.480
Sep 1,660.55 3.733
Jun 1,563.50 2.836
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-17 1 2,170.00 2,170.00 2,170.00 --
Year Ending Mar-17 1 8,287.00 8,287.00 8,287.00 --
Earnings (per share)
Year Ending Mar-17 1 22.80 22.80 22.80 --
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.14 32.93
P/E High - Last 5 Yrs. -- 40.91 45.62
P/E Low - Last 5 Yrs. -- 23.80 24.34
Beta 0.82 0.90 0.88
Price to Sales (TTM) 102.07 3.93 5.40
Price to Book (MRQ) -- 4.81 5.38
Price to Tangible Book (MRQ) -- 5.53 6.78
Price to Cash Flow (TTM) -- 23.04 23.45
% Owned Institutions -- 0.88 1.40

Dividends

  Company industry sector
Dividend Yield 0.55 1.56 1.50
Dividend Yield - 5 Year Avg -- 1.57 1.52
Dividend 5 Year Growth Rate -- 4.33 5.17
Payout Ratio(TTM) -- 45.73 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 131.11 3.57 9.00
Sales (TTM) vs TTM 1 Yr. Ago 137.06 4.66 5.38
Sales - 5 Yr. Growth Rate -- 10.11 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -95.99 16.54 19.67
EPS (TTM) vs TTM 1 Yr. Ago 68.15 -- --
EPS - 5 Yr. Growth Rate -- 9.86 10.79
Capital Spending - 5 Yr. Growth Rate -- 15.30 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.11 2.18
Current Ratio (MRQ) -- 2.88 2.98
LT Debt to Equity (MRQ) -- 9.47 11.56
Total Debt to Equity (MRQ) -- 13.43 15.81
Interest Coverage (TTM) -1.48 36.29 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 72.14 55.14 54.83
Gross Margin - 5 Yr. Avg. -- 52.29 52.40
EBITD Margin (TTM) -358.32 -- --
EBITD - 5 Yr. Avg -- 18.46 15.24
Operating Margin (TTM) -375.91 14.50 7.76
Operating Margin - 5 Yr. Avg. -- 14.42 10.75
Pre-Tax Margin (TTM) -336.83 14.95 8.57
Pre-Tax Margin - 5 Yr. Avg. -- 14.74 11.17
Net Profit Margin (TTM) -219.89 11.22 4.88
Net Profit Margin - 5 Yr. Avg. -- 11.08 7.47
Effective Tax Rate (TTM) -- 23.21 23.11
Effective Tax Rate - 5 Yr. Avg. -- 23.44 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 118,782 953,213,828 864,680,848
Net Income/Employee (TTM) -261,187 112,151,383 101,718,394
Receivable Turnover (TTM) -- 5.60 5.76
Inventory Turnover (TTM) -- 2.58 3.34
Asset Turnover (TTM) -- 0.95 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.42 11.00
Return on Assets - 5 Yr. Avg. -- 13.00 12.43
Return on Investment (TTM) -- 14.86 14.46
Return on Investment - 5 Yr. Avg. -- 17.00 16.28
Return on Equity (TTM) -- 16.28 16.05
Return on Equity - 5 Yr. Avg. -- 18.03 17.51
  1 Year 3 Year 5 Year
Sales % -80.83 -- --
EPS (TTM) % 63.72 -- --
Dividend % 0.00 -- --
Note: Units in Millions of US Dollars

Performance for Claris Lifesciences Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.19 -2.58 99 25
13 Week 0.70 -0.73 99 37
26 Week 10.79 3.45 99 30
52 Week 30.38 15.18 99 12
YTD 13.86 -4.71 99 25
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 16.89%
# of Holders: 9
Total Shares Held: 9,218,935
3 Mo. Net Change: 16,977
# New Positions: 1
# Closed Positions: 0
# Increased Positions: 2
# Reduced Positions: 1
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.